Keyphrases
HIV Patients
100%
Tissue Fibrosis
100%
Venous Thromboembolism
100%
Markers of Endothelial Dysfunction
100%
Endothelial Tissue
100%
Coagulation
100%
Venous Thromboembolic Events
100%
Plasma Parameters
66%
Endothelial Dysfunction
66%
Non-modifiable Risk Factors
66%
Inflammatory Biomarkers
66%
Venous Thrombosis
66%
Active Infection
66%
Trauma
33%
Age-matched
33%
Multivariate Analysis
33%
HIV-related
33%
No Significant Difference
33%
National Institutes of Health
33%
D-dimer
33%
Mortality Prediction
33%
Hospitalization
33%
Opportunistic Infections
33%
HIV Infection
33%
Health Studies
33%
Interleukin-2
33%
P-selectin
33%
Antiretroviral
33%
Hyaluronic Acid
33%
Cytomegalovirus Viremia
33%
Hypercoagulability
33%
Cytomegalovirus Disease
33%
Retrospective Case-Control Design
33%
Immunodeficiency
33%
Coagulation Biomarkers
33%
Coagulation Abnormalities
33%
Nadir CD4 Cell Count
33%
Lifetime History
33%
Venous Thromboembolic Disease
33%
Cytomegalovirus Reactivation
33%
HIV Viremia
33%
Event-level
33%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Fibrosis
100%
Endothelial Dysfunction
100%
Venous Thromboembolism
100%
Biological Marker
50%
Infection
25%
Cytomegalovirus
25%
P-Selectin
25%
Vein Thrombosis
25%
Viremia
25%
Injury
12%
Inflammation
12%
Enzyme-Linked Immunosorbent Assay
12%
Human Immunodeficiency Virus Infection
12%
Opportunistic Infection
12%
Case-Control Study
12%
Cytomegalovirus Infection
12%
Interleukin 2
12%
Hyaluronic Acid
12%
Thromboembolism
12%
Immune Deficiency
12%
D Dimer
12%
Hypercoagulability
12%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Blood Level
25%
Blood Plasma
25%
P-Selectin
25%
Viremia
25%
Cytomegalovirus
25%
ELISA
12%
CD4 Lymphocyte Count
12%
Lifespan
12%
Human Immunodeficiency Virus Infection
12%
Opportunistic Infection
12%
Immunodeficiency
12%
Interleukin 2
12%
Cytomegalovirus Infection
12%